Cargando…
In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets
Amorphous solid dispersion (ASD) dosage forms can improve the oral bioavailability of poorly water-soluble drugs, enabling the commercialization of new chemical entities and improving the efficacy and patient compliance of existing drugs. However, the development of robust, high-performing ASD dosag...
Autores principales: | Mudie, Deanna M., Stewart, Aaron M., Rosales, Jesus A., Adam, Molly S., Morgen, Michael M., Vodak, David T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398755/ https://www.ncbi.nlm.nih.gov/pubmed/34452217 http://dx.doi.org/10.3390/pharmaceutics13081257 |
Ejemplares similares
-
Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. Pharmaceutics 2021, 13, 1257
por: Mudie, Deanna M., et al.
Publicado: (2021) -
Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs
por: Mudie, Deanna M., et al.
Publicado: (2021) -
A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets
por: Mudie, Deanna M., et al.
Publicado: (2020) -
Water-Induced Phase Separation of Spray-Dried Amorphous
Solid Dispersions
por: Li, Na, et al.
Publicado: (2020) -
Homogenization of Amorphous Solid Dispersions Prepared by Electrospinning in Low-Dose Tablet Formulation
por: Fülöp, Gergő, et al.
Publicado: (2018)